ID   PPGB_HUMAN              Reviewed;         480 AA.
AC   P10619; B2R798; Q561W6; Q5JZH1; Q96KJ2; Q9BR08; Q9BW68;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   10-MAY-2017, entry version 207.
DE   RecName: Full=Lysosomal protective protein;
DE            EC=3.4.16.5;
DE   AltName: Full=Carboxypeptidase C;
DE   AltName: Full=Carboxypeptidase L;
DE   AltName: Full=Cathepsin A;
DE   AltName: Full=Protective protein cathepsin A;
DE            Short=PPCA;
DE   AltName: Full=Protective protein for beta-galactosidase;
DE   Contains:
DE     RecName: Full=Lysosomal protective protein 32 kDa chain;
DE   Contains:
DE     RecName: Full=Lysosomal protective protein 20 kDa chain;
DE   Flags: Precursor;
GN   Name=CTSA; Synonyms=PPGB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3136930; DOI=10.1016/S0092-8674(88)90999-3;
RA   Galjart N.J., Gillemans N., Harris A., van de Horst G.T.J.,
RA   Verheijen F.W., Galjaard H., D'Azzo A.;
RT   "Expression of cDNA encoding the human 'protective protein' associated
RT   with lysosomal beta-galactosidase and neuraminidase: homology to yeast
RT   proteases.";
RL   Cell 54:755-764(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 29-53 AND 327-351.
RC   TISSUE=Platelet;
RX   PubMed=1694176;
RA   Jackman H.L., Tan F., Tamei H., Beurling-Harbury C., Li X.-Y.,
RA   Skidgel R.A., Erdoes E.G.;
RT   "A peptidase in human platelets that deamidates tachykinins. Probable
RT   identity with the lysosomal 'protective protein'.";
RL   J. Biol. Chem. 265:11265-11272(1990).
RN   [6]
RP   PROTEIN SEQUENCE OF 29-37.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS.
RX   PubMed=1907282;
RA   Galjart N.J., Morreau H., Willemsen R., Gillemans N., Bonten E.J.,
RA   D'Azzo A.;
RT   "Human lysosomal protective protein has cathepsin A-like activity
RT   distinct from its protective function.";
RL   J. Biol. Chem. 266:14754-14762(1991).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-145.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-145 AND ASN-333.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=8591035; DOI=10.1016/S0969-2126(01)00260-X;
RA   Rudenko G., Bonten E., D'Azzo A., Hol W.G.J.;
RT   "Three-dimensional structure of the human 'protective protein':
RT   structure of the precursor form suggests a complex activation
RT   mechanism.";
RL   Structure 3:1249-1259(1995).
RN   [13]
RP   VARIANT GSL VAL-440.
RX   PubMed=1756715;
RA   Zhou X.Y., Galjart N.J., Willemsen R., Gillemans N., Galjaard H.,
RA   D'Azzo A.;
RT   "A mutation in a mild form of galactosialidosis impairs dimerization
RT   of the protective protein and renders it unstable.";
RL   EMBO J. 10:4041-4048(1991).
RN   [14]
RP   VARIANTS GSL ARG-49; ARG-65; LEU-90; ASN-249 AND CYS-395.
RX   PubMed=8514852; DOI=10.1172/JCI116472;
RA   Shimmoto M., Fukuhara Y., Itoh K., Oshima A., Sakuraba H., Suzuki Y.;
RT   "Protective protein gene mutations in galactosialidosis.";
RL   J. Clin. Invest. 91:2393-2398(1993).
RN   [15]
RP   VARIANTS GSL TYR-51; MET-132; PRO-236; ASN-249; THR-406; SER-439 AND
RP   VAL-440.
RX   PubMed=8968752; DOI=10.1093/hmg/5.12.1977;
RA   Zhou X.Y., van der Spoel A., Rottier R., Hale G., Willemsen R.,
RA   Berry G.T., Strisciuglio P., Morrone A., Zammarchi E., Andria G.,
RA   d'Azzo A.;
RT   "Molecular and biochemical analysis of protective protein/cathepsin A
RT   mutations: correlation with clinical severity in galactosialidosis.";
RL   Hum. Mol. Genet. 5:1977-1987(1996).
RN   [16]
RP   VARIANT GSL GLU-453.
RX   PubMed=10944848; DOI=10.1007/s100380070027;
RA   Takiguchi K., Itoh K., Shimmoto M., Ozand P.T., Doi H., Sakuraba H.;
RT   "Structural and functional study of K453E mutant protective
RT   protein/cathepsin A causing the late infantile form of
RT   galactosialidosis.";
RL   J. Hum. Genet. 45:200-206(2000).
CC   -!- FUNCTION: Protective protein appears to be essential for both the
CC       activity of beta-galactosidase and neuraminidase, it associates
CC       with these enzymes and exerts a protective function necessary for
CC       their stability and activity. This protein is also a
CC       carboxypeptidase and can deamidate tachykinins.
CC       {ECO:0000269|PubMed:1907282}.
CC   -!- CATALYTIC ACTIVITY: Release of a C-terminal amino acid with broad
CC       specificity. {ECO:0000255|PROSITE-ProRule:PRU10074,
CC       ECO:0000255|PROSITE-ProRule:PRU10075}.
CC   -!- SUBUNIT: Heterodimer of a 32 kDa chain and a 20 kDa chain;
CC       disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10619-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10619-2; Sequence=VSP_054832;
CC         Note=Gene prediction based on EST data.;
CC   -!- DISEASE: Galactosialidosis (GSL) [MIM:256540]: A lysosomal storage
CC       disease associated with a combined deficiency of beta-
CC       galactosidase and neuraminidase, secondary to a defect in
CC       cathepsin A. All patients have clinical manifestations typical of
CC       a lysosomal disorder, such as coarse facies, cherry red spots,
CC       vertebral changes, foam cells in the bone marrow, and vacuolated
CC       lymphocytes. Three phenotypic subtypes are recognized. The early
CC       infantile form is associated with fetal hydrops, edema, ascites,
CC       visceromegaly, skeletal dysplasia, and early death. The late
CC       infantile type is characterized by hepatosplenomegaly, growth
CC       retardation, cardiac involvement, and a normal or mildly affected
CC       mental state. The juvenile/adult form is characterized by
CC       myoclonus, ataxia, angiokeratoma, mental retardation, neurologic
CC       deterioration, absence of visceromegaly, and long survival.
CC       {ECO:0000269|PubMed:10944848, ECO:0000269|PubMed:1756715,
CC       ECO:0000269|PubMed:8514852, ECO:0000269|PubMed:8968752}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peptidase S10 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI20248.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22960; AAA36476.1; -; mRNA.
DR   EMBL; AK312898; BAG35745.1; -; mRNA.
DR   EMBL; AL008726; CAA15501.1; -; Genomic_DNA.
DR   EMBL; AL008726; CAI20248.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC000597; AAH00597.1; -; mRNA.
DR   EMBL; BC093009; AAH93009.1; -; mRNA.
DR   CCDS; CCDS46609.1; -. [P10619-1]
DR   PIR; A31589; A31589.
DR   RefSeq; NP_000299.2; NM_000308.3.
DR   RefSeq; NP_001121167.1; NM_001127695.2. [P10619-1]
DR   RefSeq; NP_001161066.1; NM_001167594.2.
DR   UniGene; Hs.609336; -.
DR   PDB; 1IVY; X-ray; 2.20 A; A/B=29-480.
DR   PDB; 3BP4; X-ray; 1.85 A; C=2-10.
DR   PDB; 3BP7; X-ray; 1.80 A; C=2-10.
DR   PDB; 3BXN; X-ray; 1.86 A; C=2-10.
DR   PDB; 4AZ0; X-ray; 2.17 A; A=29-326, B=327-480.
DR   PDB; 4AZ3; X-ray; 2.04 A; A=29-326, B=327-480.
DR   PDB; 4CI9; X-ray; 1.58 A; A=29-480.
DR   PDB; 4CIA; X-ray; 1.98 A; A=29-480.
DR   PDB; 4CIB; X-ray; 1.89 A; A=29-480.
DR   PDB; 4MWS; X-ray; 2.80 A; A/B=29-480.
DR   PDB; 4MWT; X-ray; 3.85 A; A/B=29-480.
DR   PDBsum; 1IVY; -.
DR   PDBsum; 3BP4; -.
DR   PDBsum; 3BP7; -.
DR   PDBsum; 3BXN; -.
DR   PDBsum; 4AZ0; -.
DR   PDBsum; 4AZ3; -.
DR   PDBsum; 4CI9; -.
DR   PDBsum; 4CIA; -.
DR   PDBsum; 4CIB; -.
DR   PDBsum; 4MWS; -.
DR   PDBsum; 4MWT; -.
DR   ProteinModelPortal; P10619; -.
DR   SMR; P10619; -.
DR   BioGrid; 111472; 33.
DR   IntAct; P10619; 12.
DR   MINT; MINT-3007366; -.
DR   STRING; 9606.ENSP00000361562; -.
DR   BindingDB; P10619; -.
DR   ChEMBL; CHEMBL6115; -.
DR   GuidetoPHARMACOLOGY; 1581; -.
DR   ESTHER; human-CTSA; Carboxypeptidase_S10.
DR   MEROPS; S10.002; -.
DR   iPTMnet; P10619; -.
DR   PhosphoSitePlus; P10619; -.
DR   SwissPalm; P10619; -.
DR   BioMuta; CTSA; -.
DR   DMDM; 20178316; -.
DR   OGP; P10619; -.
DR   EPD; P10619; -.
DR   MaxQB; P10619; -.
DR   PaxDb; P10619; -.
DR   PeptideAtlas; P10619; -.
DR   PRIDE; P10619; -.
DR   TopDownProteomics; P10619-1; -. [P10619-1]
DR   TopDownProteomics; P10619-2; -. [P10619-2]
DR   DNASU; 5476; -.
DR   Ensembl; ENST00000191018; ENSP00000191018; ENSG00000064601. [P10619-1]
DR   Ensembl; ENST00000372459; ENSP00000361537; ENSG00000064601. [P10619-1]
DR   GeneID; 5476; -.
DR   KEGG; hsa:5476; -.
DR   UCSC; uc002xqj.5; human. [P10619-1]
DR   CTD; 5476; -.
DR   DisGeNET; 5476; -.
DR   GeneCards; CTSA; -.
DR   HGNC; HGNC:9251; CTSA.
DR   HPA; CAB024930; -.
DR   HPA; HPA031068; -.
DR   MalaCards; CTSA; -.
DR   MIM; 256540; phenotype.
DR   MIM; 613111; gene.
DR   neXtProt; NX_P10619; -.
DR   OpenTargets; ENSG00000064601; -.
DR   Orphanet; 351; Galactosialidosis.
DR   PharmGKB; PA33572; -.
DR   eggNOG; KOG1282; Eukaryota.
DR   eggNOG; COG2939; LUCA.
DR   GeneTree; ENSGT00860000133774; -.
DR   HOVERGEN; HBG053652; -.
DR   InParanoid; P10619; -.
DR   KO; K13289; -.
DR   PhylomeDB; P10619; -.
DR   TreeFam; TF323769; -.
DR   BRENDA; 3.4.16.5; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P10619; -.
DR   SignaLink; P10619; -.
DR   ChiTaRS; CTSA; human.
DR   EvolutionaryTrace; P10619; -.
DR   GeneWiki; Cathepsin_A; -.
DR   GenomeRNAi; 5476; -.
DR   PRO; PR:P10619; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000064601; -.
DR   CleanEx; HS_CTSA; -.
DR   ExpressionAtlas; P10619; baseline and differential.
DR   Genevisible; P10619; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004180; F:carboxypeptidase activity; TAS:ProtInc.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0004308; F:exo-alpha-sialidase activity; TAS:Reactome.
DR   GO; GO:0004185; F:serine-type carboxypeptidase activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0006886; P:intracellular protein transport; TAS:ProtInc.
DR   GO; GO:1904715; P:negative regulation of chaperone-mediated autophagy; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   GO; GO:1904714; P:regulation of chaperone-mediated autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR001563; Peptidase_S10.
DR   InterPro; IPR033124; Ser_caboxypep_his_AS.
DR   InterPro; IPR018202; Ser_caboxypep_ser_AS.
DR   PANTHER; PTHR11802; PTHR11802; 1.
DR   Pfam; PF00450; Peptidase_S10; 1.
DR   PRINTS; PR00724; CRBOXYPTASEC.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00560; CARBOXYPEPT_SER_HIS; 1.
DR   PROSITE; PS00131; CARBOXYPEPT_SER_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carboxypeptidase;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lysosome; Protease;
KW   Reference proteome; Signal; Zymogen.
FT   SIGNAL        1     28       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:1694176}.
FT   CHAIN        29    480       Lysosomal protective protein.
FT                                /FTId=PRO_0000004274.
FT   CHAIN        29    326       Lysosomal protective protein 32 kDa
FT                                chain.
FT                                /FTId=PRO_0000004275.
FT   CHAIN       327    480       Lysosomal protective protein 20 kDa
FT                                chain.
FT                                /FTId=PRO_0000004276.
FT   ACT_SITE    178    178
FT   ACT_SITE    400    400       {ECO:0000250}.
FT   ACT_SITE    457    457
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    333    333       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID     88    362
FT   DISULFID    240    256
FT   DISULFID    241    246
FT   DISULFID    281    331
FT   VAR_SEQ     102    118       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_054832.
FT   VARIANT      49     49       Q -> R (in GSL; dbSNP:rs137854541).
FT                                {ECO:0000269|PubMed:8514852}.
FT                                /FTId=VAR_001385.
FT   VARIANT      51     51       S -> Y (in GSL).
FT                                {ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_063018.
FT   VARIANT      65     65       W -> R (in GSL; dbSNP:rs28934603).
FT                                {ECO:0000269|PubMed:8514852}.
FT                                /FTId=VAR_001386.
FT   VARIANT      90     90       S -> L (in GSL; dbSNP:rs137854542).
FT                                {ECO:0000269|PubMed:8514852}.
FT                                /FTId=VAR_001387.
FT   VARIANT     132    132       V -> M (in GSL; dbSNP:rs137854545).
FT                                {ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_063019.
FT   VARIANT     236    236       L -> P (in GSL; dbSNP:rs137854546).
FT                                {ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_063020.
FT   VARIANT     249    249       Y -> N (in GSL; small amount of activity;
FT                                dbSNP:rs137854544).
FT                                {ECO:0000269|PubMed:8514852,
FT                                ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_001388.
FT   VARIANT     395    395       Y -> C (in GSL; loss of activity;
FT                                dbSNP:rs137854543).
FT                                {ECO:0000269|PubMed:8514852}.
FT                                /FTId=VAR_001389.
FT   VARIANT     406    406       M -> T (in GSL; dbSNP:rs137854548).
FT                                {ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_063021.
FT   VARIANT     439    439       G -> S (in GSL; dbSNP:rs137854547).
FT                                {ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_063022.
FT   VARIANT     440    440       F -> V (in GSL; dbSNP:rs137854540).
FT                                {ECO:0000269|PubMed:1756715,
FT                                ECO:0000269|PubMed:8968752}.
FT                                /FTId=VAR_001390.
FT   VARIANT     453    453       K -> E (in GSL; dbSNP:rs137854549).
FT                                {ECO:0000269|PubMed:10944848}.
FT                                /FTId=VAR_063023.
FT   MUTAGEN     178    178       S->A: Inactivates the enzyme.
FT                                {ECO:0000269|PubMed:1907282}.
FT   MUTAGEN     457    457       H->Q: Inactivates the enzyme.
FT                                {ECO:0000269|PubMed:1907282}.
FT   CONFLICT     19     19       Missing (in Ref. 4; AAH00597).
FT                                {ECO:0000305}.
FT   CONFLICT     56     56       G -> S (in Ref. 1; AAA36476).
FT                                {ECO:0000305}.
FT   HELIX        31     33       {ECO:0000244|PDB:4CI9}.
FT   STRAND       41     43       {ECO:0000244|PDB:4CIA}.
FT   STRAND       49     55       {ECO:0000244|PDB:4CI9}.
FT   STRAND       60     67       {ECO:0000244|PDB:4CI9}.
FT   TURN         73     75       {ECO:0000244|PDB:4CI9}.
FT   STRAND       78     82       {ECO:0000244|PDB:4CI9}.
FT   TURN         85     87       {ECO:0000244|PDB:4CI9}.
FT   HELIX        91     96       {ECO:0000244|PDB:4CI9}.
FT   STRAND       99    103       {ECO:0000244|PDB:4CI9}.
FT   STRAND      110    112       {ECO:0000244|PDB:4CI9}.
FT   HELIX       117    119       {ECO:0000244|PDB:4CI9}.
FT   STRAND      120    126       {ECO:0000244|PDB:4CI9}.
FT   STRAND      136    139       {ECO:0000244|PDB:1IVY}.
FT   HELIX       146    163       {ECO:0000244|PDB:4CI9}.
FT   HELIX       165    167       {ECO:0000244|PDB:4CI9}.
FT   STRAND      168    170       {ECO:0000244|PDB:4MWS}.
FT   STRAND      172    177       {ECO:0000244|PDB:4CI9}.
FT   HELIX       180    192       {ECO:0000244|PDB:4CI9}.
FT   STRAND      199    206       {ECO:0000244|PDB:4CI9}.
FT   HELIX       211    224       {ECO:0000244|PDB:4CI9}.
FT   HELIX       230    240       {ECO:0000244|PDB:4CI9}.
FT   HELIX       254    268       {ECO:0000244|PDB:4CI9}.
FT   STRAND      269    271       {ECO:0000244|PDB:4CI9}.
FT   STRAND      286    292       {ECO:0000244|PDB:1IVY}.
FT   STRAND      295    298       {ECO:0000244|PDB:1IVY}.
FT   HELIX       315    317       {ECO:0000244|PDB:1IVY}.
FT   HELIX       318    321       {ECO:0000244|PDB:1IVY}.
FT   STRAND      324    327       {ECO:0000244|PDB:1IVY}.
FT   HELIX       335    341       {ECO:0000244|PDB:4CI9}.
FT   HELIX       344    349       {ECO:0000244|PDB:4CI9}.
FT   HELIX       364    369       {ECO:0000244|PDB:4CI9}.
FT   STRAND      375    377       {ECO:0000244|PDB:4CI9}.
FT   HELIX       378    386       {ECO:0000244|PDB:4CI9}.
FT   STRAND      391    397       {ECO:0000244|PDB:4CI9}.
FT   STRAND      401    403       {ECO:0000244|PDB:4CI9}.
FT   HELIX       405    414       {ECO:0000244|PDB:4CI9}.
FT   STRAND      424    429       {ECO:0000244|PDB:4CI9}.
FT   HELIX       431    433       {ECO:0000244|PDB:4CI9}.
FT   STRAND      435    444       {ECO:0000244|PDB:4CI9}.
FT   STRAND      447    452       {ECO:0000244|PDB:4CI9}.
FT   HELIX       459    462       {ECO:0000244|PDB:4CI9}.
FT   HELIX       464    475       {ECO:0000244|PDB:4CI9}.
SQ   SEQUENCE   480 AA;  54466 MW;  46B737DEE775C508 CRC64;
     MIRAAPPPLF LLLLLLLLLV SWASRGEAAP DQDEIQRLPG LAKQPSFRQY SGYLKGSGSK
     HLHYWFVESQ KDPENSPVVL WLNGGPGCSS LDGLLTEHGP FLVQPDGVTL EYNPYSWNLI
     ANVLYLESPA GVGFSYSDDK FYATNDTEVA QSNFEALQDF FRLFPEYKNN KLFLTGESYA
     GIYIPTLAVL VMQDPSMNLQ GLAVGNGLSS YEQNDNSLVY FAYYHGLLGN RLWSSLQTHC
     CSQNKCNFYD NKDLECVTNL QEVARIVGNS GLNIYNLYAP CAGGVPSHFR YEKDTVVVQD
     LGNIFTRLPL KRMWHQALLR SGDKVRMDPP CTNTTAASTY LNNPYVRKAL NIPEQLPQWD
     MCNFLVNLQY RRLYRSMNSQ YLKLLSSQKY QILLYNGDVD MACNFMGDEW FVDSLNQKME
     VQRRPWLVKY GDSGEQIAGF VKEFSHIAFL TIKGAGHMVP TDKPLAAFTM FSRFLNKQPY
//
